Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer?

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Stanford University.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
California Breast Cancer Research Program
Genentech, Inc.
Amgen
Johnson & Johnson
Google
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00186602
First received: September 14, 2005
Last updated: October 4, 2006
Last verified: September 2005
  Purpose

Women indicate the greatest needs for counseling at the time of initial diagnosis for primary breast cancer. The time of initial diagnosis is also often the time of greatest need for information for women and their families. However, this is the time when a woman, overwhelmed by shock and trauma, is least likely to absorb information provided or seek new sources of information. An informed peer navigator with carefully trained communication skills can judge the level of information to disclose and pace that information in a way that can be easily absorbed and understood. She will also provide support. WomenCARE, a well-established Santa Cruz agency providing free support services for women with cancer, and the Psychosocial Treatment Lab at Stanford therefore ask whether women newly diagnosed with breast cancer will improve their quality of life by participating in a peer navigator program. WomenCARE's peer navigators provide emotional support, good listening skills, and information on resources for women just diagnosed with breast cancer. Having a peer counselor while a woman goes through treatment may reduce the magnitude of distress or shorten its time course. It may also reduce distress in family members, and improve relationships with medical personnel.

This study is designed to evaluate the effectiveness of a peer navigator program where a woman newly diagnosed with breast cancer is carefully matched for 3 to 6 months after diagnosis with a trained volunteer who is herself a breast cancer survivor. Navigators and Sojourners (newly diagnosed women) are matched on things that are important to them. Women often want to be matched on the type of surgery or treatment they have received. We assign half of the women (by a process similar to a coin toss) to our peer navigator program and half to a group that receives standard medical care but no peer navigator. In this way we can compare the groups to see whether those matched with a peer navigator have better quality of life over the 3 to 6 month period. All women who join our study, regardless of the group to which they are assigned, get an extra consultation with a nurse specialist at a local hospital. In this consultation, the nurse reviews the cancer resources available to the woman in Santa Cruz County. This meeting is tailored to the woman’s individual diagnosis and situation.


Condition Intervention Phase
Breast Cancer
Behavioral: Peer counseling
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: Does a Peer Navigator Improve Quality of Life at Diagnosis?

Resource links provided by NLM:


Further study details as provided by Stanford University:

  Eligibility

Ages Eligible for Study:   20 Years to 85 Years
Genders Eligible for Study:   Female
Criteria

Inclusion Criteria:

women within 2 months of diagnosis of breast cancer can read English within the catchment area of Watsonville and Santa Cruz California -

Exclusion Criteria:

women who have previously had a peer navigator intervention women who have a chronic history of hospitalization for psychiatric reason

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00186602

Locations
United States, California
WomenCARE
Santa Cruz, California, United States, 95061
Sponsors and Collaborators
Stanford University
California Breast Cancer Research Program
Genentech, Inc.
Amgen
Johnson & Johnson
Google
Investigators
Principal Investigator: David Spiegel, M.D. Stanford University
Principal Investigator: Caroline Bliss-Isberg, Ph.D. Cabrillo College
Study Director: Janine Giese-Davis, Ph.D. Stanford University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00186602     History of Changes
Other Study ID Numbers: 7BB-2400
Study First Received: September 14, 2005
Last Updated: October 4, 2006
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on October 19, 2014